Short answer
Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Corporate name changed from Olema Pharmaceuticals, Inc. to Olema Oncology, Inc. effective November 12, 2026.
Olema Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Corporate name changed from Olema Pharmaceuticals, Inc. to Olema Oncology, Inc. effective November 12, 2026
- Name change required no stockholder approval, reducing execution friction
- Common stock continues trading on Nasdaq Global Select Market under ticker OLMA
- Amended bylaws updated to reflect the new corporate name
Item 7.01 · Regulation FD Disclosure
- Olema Oncology announced a corporate name change on November 12, 2026
- Name change may affect ticker, branding, investor communications and corporate records
- Investors should review Exhibit 99.1 for the new name and implementation details
Item 8.01 · Other Events
- Principal executive offices relocated effective November 12, 2026
- New headquarters: 365 Oyster Point Blvd., Suite 400, South San Francisco, California
- Administrative change with limited direct impact on operations or shareholder economics
Item EX-99.1 · Exhibit EX-99.1
- Corporate name changed to Olema Oncology, Inc. effective November 12, 2026
- Nasdaq listing and ticker unchanged: OLMA on the Nasdaq Global Select Market
- No stockholder vote required, limiting immediate governance or ownership disruption
- Rebranding emphasizes oncology focus as palazestrant advances through two Phase 3 trials
- OP-3136 remains in Phase 1 development, extending the company’s pipeline beyond palazestrant
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Olema Pharmaceuticals, Inc. 8-K filings
Get the next OLMA 8-K as it lands
Follow OLMA for push alerts, or ask the research agent what this filing means.